Coheris SA (LON:0OK9)
14.45
+0.10 (0.70%)
At close: Oct 23, 2025
Coheris Revenue
Coheris had revenue of 7.90M EUR in the half year ending June 30, 2025, with 5.48% growth. This brings the company's revenue in the last twelve months to 15.47M, up 6.71% year-over-year. In the year 2024, Coheris had annual revenue of 14.94M with 2.18% growth.
Revenue (ttm)
15.47M EUR
Revenue Growth
+6.71%
P/S Ratio
5.32
Revenue / Employee
221.00K EUR
Employees
70
Market Cap
70.59M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 14.94M | 319.00K | 2.18% |
| Dec 31, 2023 | 14.62M | 783.00K | 5.66% |
| Dec 31, 2022 | 13.84M | 1.44M | 11.62% |
| Dec 31, 2021 | 12.40M | 995.00K | 8.73% |
| Dec 31, 2020 | 11.40M | -1.46M | -11.35% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 198.54B |
| BP p.l.c. | 134.89B |
| Unilever | 51.24B |
| AstraZeneca | 41.24B |
| HSBC Holdings | 41.03B |
| Rio Tinto Group | 39.22B |
| GSK plc | 31.63B |
| British American Tobacco p.l.c. | 25.60B |